Max E. Scheulen
Essen, NW 45147, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM).
Journal: iScience
Published: May 23, 2025
Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US).
Journal: Journal of cancer research and clinical oncology
Published: February 16, 2021
Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center.
Journal: Journal of cancer research and clinical oncology
Published: February 01, 2020
A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: February 16, 2016
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study.
Journal: Journal of hepatology
Published: September 18, 2015
Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS).
Journal: Journal of gastrointestinal cancer
Published: February 25, 2015
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 23, 2014
FOLFIRI and sunitinib as first-line treatment in metastatic colorectal cancer patients with liver metastases--a CESAR phase II study including pharmacokinetic, biomarker, and imaging data.
Journal: International journal of clinical pharmacology and therapeutics
Published: May 08, 2014
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 14, 2014
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 11, 2014
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 30, 2013
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors.
Journal: British journal of cancer
Published: September 11, 2013
Last Updated: 09/26/2026